Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$81.5M |
| 2 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$40.9M |
| 3 |
American Express
AXP
|
+$15.4M |
| 4 |
Microsoft
MSFT
|
+$74.6K |
| 5 |
MSCI
MSCI
|
+$22.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$137M |
| 2 |
Halliburton
HAL
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.06% |
| 2 | Healthcare | 15.55% |
| 3 | Energy | 14.67% |
| 4 | Financials | 12.48% |
| 5 | Communication Services | 7.45% |
Similar funds
Mason Morfit's Q3 2015 Portfolio in Review
As of Q3 2015, Mason Morfit held 15 positions worth $17.2B, down 9.4% from $19B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Mason Morfit's Q3 2015 filing shows 1 new, 4 increased and 2 reduced positions. Its largest new stake was TOWERS WATSON & CO COM STK CL A (DE): 330,000 shares worth $38.7M. The largest sale was Adobe, an estimated $137M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Energy.
- Mason Morfit's largest Q3 2015 buy was TOWERS WATSON & CO COM STK CL A (DE): 330,000 shares worth $38.7M.
- Mason Morfit added most to Twenty-First Century Fox, Inc. Class B in Q3 2015, an estimated $81.5M increase.
- Mason Morfit's biggest Q3 2015 reduction was Adobe, cutting an estimated $137M.
- Mason Morfit's ten largest holdings make up 87% of its $17.2B portfolio in Q3 2015.
- Mason Morfit opened 1 new position and closed 0 in Q3 2015.
- Mason Morfit's portfolio value fell 9.4% quarter-over-quarter to $17.2B.
Based on ValueAct Holdings's 13F filing for Q3 2015, filed 16 Nov 2015.